Aberdeen Asset Management PLC UK grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 0.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 388,327 shares of the conglomerate’s stock after purchasing an additional 1,298 shares during the period. Aberdeen Asset Management PLC UK owned about 0.06% of Danaher Corporation worth $32,771,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of DHR. Waldron LP purchased a new stake in shares of Danaher Corporation during the first quarter worth approximately $320,000. Empire Life Investments Inc. increased its stake in shares of Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock worth $6,662,000 after buying an additional 1,764 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Danaher Corporation by 4.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 355,219 shares of the conglomerate’s stock worth $30,382,000 after buying an additional 14,462 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of Danaher Corporation during the first quarter worth approximately $648,000. Finally, Swiss National Bank increased its stake in shares of Danaher Corporation by 24.0% during the first quarter. Swiss National Bank now owns 2,569,144 shares of the conglomerate’s stock worth $219,739,000 after buying an additional 496,900 shares during the period. Institutional investors own 75.69% of the company’s stock.
A number of analysts recently weighed in on DHR shares. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $92.62.
In other news, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider William King sold 43,688 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the sale, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 over the last quarter. Company insiders own 12.20% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Stock Observer and is owned by of Stock Observer. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.thestockobserver.com/2017/10/13/aberdeen-asset-management-plc-uk-acquires-1298-shares-of-danaher-corporation-dhr.html.
Danaher Corporation (NYSE DHR) opened at 87.03 on Friday. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62. The firm has a market capitalization of $60.46 billion, a P/E ratio of 27.78 and a beta of 1.03. The company has a 50-day moving average price of $85.70 and a 200-day moving average price of $84.21.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the business earned $0.90 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts anticipate that Danaher Corporation will post $3.96 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. Danaher Corporation’s dividend payout ratio (DPR) is 17.83%.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.